Haematologica (Mar 2023)
Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy
- Naseema Gangat,
- Rimal Ilyas,
- Isla M Johnson,
- Kristen McCullough,
- Aref Al-Kali,
- Hassan B Alkhateeb,
- Kebede H Begna,
- Abhishek Mangaonkar,
- Mark R Litzow,
- William Hogan,
- Mithun Shah,
- Mrinal M Patnaik,
- Animesh Pardanani,
- Ayalew Tefferi
Affiliations
- Naseema Gangat
- Division of Hematology, Mayo Clinic, Rochester, MN
- Rimal Ilyas
- Division of Hematology, Mayo Clinic, Rochester, MN
- Isla M Johnson
- Division of Hematology, Mayo Clinic, Rochester, MN
- Kristen McCullough
- Division of Hematology, Mayo Clinic, Rochester, MN
- Aref Al-Kali
- Division of Hematology, Mayo Clinic, Rochester, MN
- Hassan B Alkhateeb
- Division of Hematology, Mayo Clinic, Rochester, MN
- Kebede H Begna
- Division of Hematology, Mayo Clinic, Rochester, MN
- Abhishek Mangaonkar
- Division of Hematology, Mayo Clinic, Rochester, MN
- Mark R Litzow
- Division of Hematology, Mayo Clinic, Rochester, MN
- William Hogan
- Division of Hematology, Mayo Clinic, Rochester, MN
- Mithun Shah
- Division of Hematology, Mayo Clinic, Rochester, MN
- Mrinal M Patnaik
- Division of Hematology, Mayo Clinic, Rochester, MN
- Animesh Pardanani
- Division of Hematology, Mayo Clinic, Rochester, MN
- Ayalew Tefferi
- Division of Hematology, Mayo Clinic, Rochester, MN
- DOI
- https://doi.org/10.3324/haematol.2022.282677
- Journal volume & issue
-
Vol. 108,
no. 11
Abstract
No abstracts available.
